# EvoAI Hub Pitch Deck

**Deck Overview**: This pitch deck presents EvoAI Hub, a high-level Adaptive Intelligence API powered by Transposable Element AI (TE-AI). It enables evolutionary problem-solving across industries, with subdomain accelerators like High-Throughput Screening (HTS) for biotech. Built for scalability, it captures the $55-100B AIaaS market by 2030.<grok:render card_id="4ae894" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">10</argument>
</grok:render> The deck follows a streamlined 11-slide structure inspired by Sequoia's timeless guide, adapted for 2025 AI/SaaS trends: focus on AI's transformative edge, rapid ROI, and data flywheels.<grok:render card_id="d28f95" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">24</argument>
</grok:render> Visuals: Clean, modern design (e.g., Notion/Canva templates) with AI evolution animations, graphs, and demo screenshots.<grok:render card_id="338ff7" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">9</argument>
</grok:render><grok:render card_id="920169" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">14</argument>
</grok:render> Target audience: VCs/investors in AI/biotech (e.g., Lightspeed, Sequoia).<grok:render card_id="a9fc7c" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">2</argument>
</grok:render>

---

### Slide 1: Title / Company Purpose

- **Visuals**: Logo (evolving DNA helix into API icon), tagline: "Evolve Intelligence for Any Challenge."
- **Content**:
  - EvoAI Hub: The bio-inspired AI engine that adapts like nature—powering cross-industry solutions via a high-level API and accelerators.
  - Mission: Democratize evolutionary AI to solve complex, dynamic problems, starting with biotech HTS.
  - Founded 2025 | Team: AI experts from xAI-inspired backgrounds.
  - (Subtle note: "We're not just AI—we're alive."<grok:render card_id="06c0a2" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">0</argument>
    </grok:render>)

---

### Slide 2: Problem

- **Visuals**: Infographic: Traditional AI silos (static models failing in volatile data); stats: 90% drug failures cost $2.5B each; AIaaS fragmentation wastes $100B/year in custom dev.<grok:render card_id="45eeca" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">10</argument>
  </grok:render><grok:render card_id="216824" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">12</argument>
  </grok:render>
- **Content**:
  - Industries face adaptive challenges: Biotech screens millions of targets inefficiently; finance strategies crash in volatility; robotics needs real-time evolution.
  - Current tools: Rigid APIs lack bio-like adaptation (mutation, stress response).
  - Pain Points: High dev costs ($M for custom AI), slow iteration (months vs. hours), no cross-domain reuse.
  - Market Gap: $55-100B AIaaS by 2030, but most lack evolutionary intelligence.<grok:render card_id="ea7b30" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">10</argument>
    </grok:render><grok:render card_id="16a09c" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">11</argument>
    </grok:render>

---

### Slide 3: Solution

- **Visuals**: Architecture diagram: Core API (TE-AI engine) → Sub-services (HTS wrapper) → Outputs (evolved solutions + metrics). Demo GIF: Omics upload → HTS ranks targets via API call.
- **Content**:
  - EvoAI Engine: High-level API for bio-inspired evolution—upload data, get adaptive solutions (e.g., ranked targets, strategies).
  - Key Features: Transposition for rapid shifts, stem genes for malleability, quantum for probabilistic sims, data flywheel for benchmarks.
  - Accelerators: Domain-specific wrappers (e.g., HTS for biotech—narrows targets 10x faster, built on the API as proof-of-concept).
  - How It Works: Data as "antigens" → Evolve "genes" → Ranked adaptations + stats.
  - Differentiation: Unlike static APIs (Hugging Face), we evolve in real-time like biology.<grok:render card_id="82dc7d" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">2</argument>
    </grok:render>

---

### Slide 4: Why Now?

- **Visuals**: Timeline: 2023 AI boom → 2025 evolutionary AI trends (agents, AutoML); stats: $8.5B AI biotech investments in 2024.<grok:render card_id="177200" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">4</argument>
  </grok:render><grok:render card_id="661e96" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">12</argument>
  </grok:render>
- **Content**:
  - AI Evolution Surge: Advances in bio-inspired AI (e.g., TE genomics) meet cloud scalability.
  - Market Readiness: Pharma/biotech demand HTS APIs ($20-64B by 2030); cross-industry AIaaS exploding.<grok:render card_id="f22ce7" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">10</argument>
    </grok:render><grok:render card_id="7d806b" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">15</argument>
    </grok:render><grok:render card_id="75ad04" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">16</argument>
    </grok:render>
  - Tech Enablers: PyTorch/GPUs for fast evolution; 2025 trends like AI agents align with our "living" system.<grok:render card_id="ebdb8b" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">3</argument>
    </grok:render>
  - Opportunity: Post-ChatGPT, investors seek adaptive AI beyond LLMs—our TE-AI fills the gap.

---

### Slide 5: Market Potential

- **Visuals**: TAM/SAM/SOM pyramid: TAM $100B AIaaS + $600B biotech; SAM $20B drug discovery AI; SOM $2B HTS APIs.<grok:render card_id="38ca76" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">10</argument>
  </grok:render><grok:render card_id="71ba42" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">11</argument>
  </grok:render><grok:render card_id="adf851" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">12</argument>
  </grok:render><grok:render card_id="3df95a" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">15</argument>
  </grok:render> Growth charts (CAGR 26-40%).
- **Content**:
  - TAM: $55-100B AIaaS by 2030; expansions to finance ($64B), robotics ($37B), manufacturing ($70B).<grok:render card_id="50a81f" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">10</argument>
    </grok:render><grok:render card_id="2deeca" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">11</argument>
    </grok:render>
  - SAM: $20B AI drug discovery; HTS subset $5-10B.
  - SOM: 10K biotech users x $1K/mo = $120M ARR potential.
  - Customers: Pharma (e.g., Pfizer), researchers (academia), enterprises (white-label).
  - Trends: 2025 AI agents boom—our evolutionary API powers them.<grok:render card_id="855dbd" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">3</argument>
    </grok:render>

---

### Slide 6: Competition / Alternatives

- **Visuals**: 2x2 Matrix: X=Adaptivity (static vs. evolutionary), Y=Scalability (niche vs. cross-domain). EvoAI top-right; competitors: Open Targets (free/static biotech), Hugging Face (ML but no evolution), Insilico (AI discovery but no API generality).<grok:render card_id="6ca6b7" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">2</argument>
  </grok:render><grok:render card_id="bcd35a" card_type="citation_card" type="render_inline_citation">
  <argument name="citation_id">8</argument>
  </grok:render>
- **Content**:
  - Direct: AI HTS tools (e.g., SwissTargetPrediction—static/free).<grok:render card_id="607750" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">2</argument>
    </grok:render> We win: Evolutionary adaptation for dynamic data.
  - Indirect: General AIaaS (e.g., AWS SageMaker—no bio-inspiration).
  - Moat: Patented TE-AI (transposition, stem genes); data flywheel from sub-services.
  - Why We Win: Category-defining (evolutionary AI); HTS as proof.<grok:render card_id="69fe65" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">2</argument>
    </grok:render>

---

### Slide 7: Business Model

- **Visuals**: Revenue streams pie: 40% Core API usage, 40% Sub-services subs, 20% White-label/Enterprise.
- **Content**:
  - Freemium API: 1K queries free, then $0.01-0.10/evolution.
  - Sub-Services (e.g., HTS): $999-9,999/mo tiers (unlimited screens + dashboards).
  - White-Label: $50K/year licenses (custom branding).
  - Path to Profit: $1M ARR Year 1 (100 HTS users); scale to $100M by Year 3 via expansions.
  - Unit Economics: CAC $500 (content marketing), LTV $10K+ (sticky API usage).

---

### Slide 8: Product / Traction

- **Visuals**: Screenshots: API docs, HTS dashboard demo. Metrics graph: Simulated 1K queries, 95% satisfaction.
- **Content**:
  - MVP Launch: Q4 2025—Core API beta, HTS accelerator.
  - Traction (Projected): 500 beta users (from X/biotech forums), 10K targets screened in tests.<grok:render card_id="bfd9cd" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">0</argument>
    </grok:render>
  - Early Wins: HTS benchmarked vs. Open Targets (10x faster adaptation).<grok:render card_id="8136f2" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">3</argument>
    </grok:render>
  - Roadmap: Finance accelerator Q1 2026; full white-label Q2.

---

### Slide 9: Team

- **Visuals**: Photos/bios.
- **Content**:
  - Founder/CEO: [You]—AI innovator, xAI alum, visionary behind TE-AI.
  - CTO: Bio-AI expert (PhD in computational biology).
  - Advisors: Pharma VC (e.g., from Retro Biosciences), AI ethicist.
  - Why Us: Obsessed with bio-inspired AI; prior exits in tech/biotech.<grok:render card_id="43a646" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">2</argument>
    </grok:render>

---

### Slide 10: Financials / Projections

- **Visuals**: 3-Year Projections: Revenue $1M Y1 → $50M Y3; Burn $2M seed.
- **Content**:
  - Y1: $1-5M ARR (HTS launch).
  - Expenses: $1M (dev/marketing).
  - Break-Even: Month 12.
  - Assumptions: 20% MoM growth, based on AIaaS trends (CAGR 39%).<grok:render card_id="24370b" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">10</argument>
    </grok:render><grok:render card_id="52e9a9" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">11</argument>
    </grok:render>

---

### Slide 11: Vision / Ask

- **Visuals**: Future world: EvoAI powering 1M evolutions/day across industries.
- **Content**:
  - Vision: The standard for adaptive AI—evolving solutions to humanity's toughest problems, from drugs to climate.
  - Ask: $3M Seed at $15M pre (20% equity) for team expansion, API scaling, HTS marketing.
  - Use of Funds: 40% Eng, 30% Sales, 20% Ops, 10% Legal/Patents.
  - Exit: Acquire by Google/Microsoft for $1B+ (AI tools space).<grok:render card_id="e07010" card_type="citation_card" type="render_inline_citation">
    <argument name="citation_id">8</argument>
    </grok:render>

**Closing Notes**: Keep under 15min pitch; focus on demo (HTS live). Practice: Tell a story of adaptation.<grok:render card_id="dfd573" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">7</argument>
</grok:render> Tools like Slidebean/Pitch.com for design.<grok:render card_id="e35356" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">21</argument>
</grok:render><grok:render card_id="503150" card_type="citation_card" type="render_inline_citation">
<argument name="citation_id">11</argument>
</grok:render> Questions?
